Search Result "Biased agonism. Bone metabolism"
A Pharmacological Primer of Biased Agonism
Journal: Endocrine, Metabolic & Immune Disorders - Drug Targets
Volume: 11 Issue: 2 Year: 2011 Page: 92-98
Author(s): Bradley T. Andresen
Biased Agonism at the Parathyroid Hormone Receptor: A Demonstration of Functional Selectivity in Bone Metabolism
Journal: Mini-Reviews in Medicinal Chemistry
Volume: 12 Issue: 9 Year: 2012 Page: 856-865
Author(s): B. N. Bohinc,D. Gesty-Palmer
β-arrestin-Biased Agonism at the Parathyroid Hormone Receptor Uncouples Bone Formation from Bone Resorption
Journal: Endocrine, Metabolic & Immune Disorders - Drug Targets
Volume: 11 Issue: 2 Year: 2011 Page: 112-119
Author(s): Brittany N. Bohinc, Diane Gesty-Palmer
New Insights in Cannabinoid Receptor Structure and Signaling
Journal: Current Molecular Pharmacology
Volume: 12 Issue: 3 Year: 2019 Page: 239-248
Author(s): Lingyan Ye,Zheng Cao,Weiwei Wang,Naiming Zhou
G Protein-Coupled Receptors â Potential Roles in Clinical Pharmacology
Journal: Cardiovascular & Hematological Agents in Medicinal Chemistry
Volume: 12 Issue: 1 Year: 2014 Page: 29-33
Author(s): Megan Kypreos,Teesta Banerjee,Debabrata Mukherjee
Recent Advances on Type-2 Cannabinoid (CB2) Receptor Agonistsand their Therapeutic Potential
Journal: Current Medicinal Chemistry
Volume: 30 Issue: 12 Year: 2023 Page: 1420-1457
Author(s):
Is Adult Hippocampal Neurogenesis Really Relevant for the Treatment of Psychiatric Disorders?
Journal: Current Neuropharmacology
Volume: 18 Issue: 0 Year: 2020 Page: 1-21
Author(s): Marco Carli,Stefano Aringhieri,Shivakumar Kolachalam,Biancamaria Longoni,Giovanna Grenno,Mario Rossi,Angelo Gemignani,Francesco Fornai,Roberto Maggio,Marco Scarselli
Emerging Opportunities and Concerns for Drug Discovery at Serotonin 5-5-HT2B Receptors
Journal: Current Topics in Medicinal Chemistry
Volume: 10 Issue: 5 Year: 2010 Page: 493-503
Author(s): Jose Brea, Julio Castro-Palomino, Sandra Yeste, Elena Cubero, Antonio Parraga, Eduardo Dominguez, Maria Isabel Loza
Editorial [Hot topic: Brave New World? Arrestin Pathway Bias in Drug Design (Guest Editor: Bradley T. Andresen)]
Journal: Endocrine, Metabolic & Immune Disorders - Drug Targets
Volume: 11 Issue: 2 Year: 2011 Page: 90-91
Author(s): Bradley T. Andresen, Louis M. Luttrell
Peptide Drugs: Current Status and Treatment for the Treatment ofVarious Diseases
Journal: Current Drug Research Reviews
Volume: 16 Issue: 3 Year: 2024 Page: 381-394
Author(s):